Speaker illustration

Doctor William Parker

University of Sheffield, Sheffield (United Kingdom of Great Britain & Northern Ireland)

Member of:

European Society of Cardiology

Clinical Lecturer and Specialist Registrar in Cardiology, University of Sheffield and Sheffield Teaching Hospitals NHS Foundation Trust. Research interests in antithrombotic therapy and other aspects of vascular prevention.

Interactions between aspirin and ticagrelor during experimental human endotoxaemia

Event: ESC Congress 2023

Topic: Pharmacotherapy

Session: Pharmacology in coronary artery disease


Does deactivation of a site's surgical cardiac transplant program affect the long-term survival of its recipients?

Event: Heart Failure 2018

Topic: Heart Transplantation

Session: Chronic Heart Failure – Treatment


Ultra-low-dose twice-daily aspirin improves haemostasis and maintains platelet inhibition in acute coronary syndrome patients receiving ticagrelor

Event: Acute Cardiovascular Care 2018

Topic: Acute Coronary Syndromes: Antiplatelet Agents

Session: Anti-thrombotics in patients at simultaneous risk of stroke and stent thrombosis


ESC 365 is supported by